GAD-67 Activators

Common GAD-67 Activators include, but are not limited to Valproic Acid CAS 99-66-1, Lithium CAS 7439-93-2, Retinoic Acid, all trans CAS 302-79-4, Fluoxetine hydrochloride CAS 56296-78-7 and Taurine CAS 107-35-7.

GAD-67 activators belong to a chemical class of compounds designed to modulate the activity of the enzyme Glutamate Decarboxylase-67 (GAD-67). GAD-67 is a critical enzyme in the central nervous system, responsible for the conversion of glutamate, an excitatory neurotransmitter, into gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. This conversion is vital for maintaining the balance between excitation and inhibition in the brain, which is crucial for proper brain function.

The activators of GAD-67 are designed to enhance the enzyme's activity, ultimately leading to an increase in GABA production. This modulation of GABA levels can have profound effects on neuronal signaling and excitability. GABA is known to play a crucial role in regulating anxiety, mood, and overall brain excitability. Therefore, GAD-67 activators pave the way for research aimed at understanding and manipulating neural circuits associated with various neurological and psychiatric disorders. By modulating GABA levels through GAD-67 activation, researchers can investigate the impact on neural circuits and develop new insights into the underlying mechanisms of conditions like epilepsy, anxiety disorders, and mood disorders. Additionally, these compounds may serve as valuable tools in the study of basic neuroscience, helping researchers unravel the complexities of the brain's intricate signaling systems.